Purchases and Sales Made in Q1 2024 in Arcutis Biotherapeutics, Inc. (ARQT)
This table provides information about the institutional ownership of Arcutis Biotherapeutics, Inc. (ARQT) during Q1 2024. The information is specifically focused on institutions that hold shares of Arcutis Biotherapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
May 15, 2024
Q1 2024
|
Two Sigma Investments, LP
New York, NY |
SELL
|
- |
-495K- 50.54% |
$1.61M - $5.82M
|
484K
$6.88M
|
|
|
May 15, 2024
Q1 2024
|
Suvretta Capital Management, LLC
New York, NY |
SELL
|
- |
-596K- 7.03% |
$1.94M - $7.01M
|
7.88M
$112M
|
|
|
May 15, 2024
Q1 2024
|
Ameriprise Financial Inc
Minneapolis, MN |
SELL
|
- |
-986K- 91.3% |
$3.2M - $11.6M
|
93.9K
$1.34M
|
|
|
May 15, 2024
Q1 2024
|
Bain Capital Life Sciences Investors, LLC
Boston, MA |
SELL
|
- |
-988K- 32.94% |
$3.21M - $11.6M
|
2.01M
$28.6M
|
|
|
May 15, 2024
Q1 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-2.08M- 34.14% |
$6.75M - $24.4M
|
4.01M
$57M
|
|
|
Aug 16, 2024
Q1 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-2.08M- 34.14% |
$6.75M - $24.4M
|
4.01M
$57M
|
|
|
May 15, 2024
Q1 2024
|
Israel Englander
Millennium Management LLC | New York, Ny
|
SELL
|
- |
-2.18M- 85.19% |
$7.08M - $25.7M
|
379K
$5.39M
|